Acute Severe Autoimmune Hepatitis: Corticosteroids or Liver Transplantation?
George N. Dalekos, Nikolaos K. Gatselis, Kalliopi Zachou – 29 July 2019
Methyl‐Sensing Nuclear Receptor Liver Receptor Homolog‐1 Regulates Mitochondrial Function in Mouse Hepatocytes
Sungwoo Choi, Bingning Dong, Chih‐Chun Janet Lin, Mi Jeong Heo, Kang Ho Kim, Zhen Sun, Martin Wagner, Nagireddy Putluri, Jae Myoung Suh, Meng C. Wang, David D. Moore – 29 July 2019
4‐1BB Delineates Distinct Activation Status of Exhausted Tumor‐Infiltrating CD8+ T Cells in Hepatocellular Carcinoma
Hyung‐Don Kim, Seongyeol Park, Seongju Jeong, Yong Joon Lee, Hoyoung Lee, Chang Gon Kim, Kyung Hwan Kim, Seung‐Mo Hong, Jung‐Yun Lee, Sunghoon Kim, Hong Kwan Kim, Byung Soh Min, Jong Hee Chang, Young Seok Ju, Eui‐Cheol Shin, Gi‐Won Song, Shin Hwang, Su‐Hyung Park – 28 July 2019
Guidance for Optimal Port Placement in Pure 3‐Dimensional Laparoscopic Donor Right Hepatectomy
Jeong‐Moo Lee, Ahmed Shehta, Kyung‐Suk Suh, Suk Kyun Hong, Kyung Chul Yoon, Jae‐Hyung Cho, Nam‐Joon Yi, Kwang‐Woong Lee – 26 July 2019
LiverLearning®: 2019 Webinar: The 2018 Primary Biliary Cholangitis Practice Guidance: Highlights
In this webinar, Drs. Marlyn Mayo and Cynthia Levy will discuss the most important recommendations included in the 2018 PBC Practice Guidance document. We will utilize a prerecorded webinar format for on-demand viewing on Liver Learning ® .Cynthia Levy Cynthia Levy, MD, FAASLD is a Professor of Medicine in the Division of Digestive Health and Liver Diseases and is the Associate Director of the Schiff Center for Liver Diseases at the University of Miami. She was awarded the Arthur Hertz Endowed Chair in Liver Diseases. Dr. Levy received her M.D.
Role of Living Donor Liver Transplantation in Acute Liver Failure
Amar Gupta, Sumeet K. Asrani – 25 July 2019
Modulation of the Tryptophan Hydroxylase 1/Monoamine Oxidase‐A/5‐Hydroxytryptamine/5‐Hydroxytryptamine Receptor 2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During Cholestasis
Konstantina Kyritsi, Lixian Chen, April O’Brien, Heather Francis, Travis W. Hein, Julie Venter, Nan Wu, Ludovica Ceci, Tianhao Zhou, David Zawieja, Anatoliy A. Gashev, Fanyin Meng, Pietro Invernizzi, Luca Fabris, Chaodong Wu, Nicholas J. Skill, Romil Saxena, Suthat Liangpunsakul, Gianfranco Alpini, Shannon S. Glaser – 25 July 2019
Reply
Xiu‐Ping Zhang, Yu‐Zhen Gao, Zhen‐Hua Chen, Shu‐Qun Cheng – 25 July 2019
Surgical Management of Ciliated Hepatic Foregut Cyst
Ioannis A. Ziogas, Dirk J. Windt, Gregory C. Wilson, Alessandro Furlan, Michael A. Nalesnik, Samer Tohme, David A. Geller – 25 July 2019
Redefining Cirrhotic Cardiomyopathy for the Modern Era
Manhal Izzy, Lisa B. VanWagner, Grace Lin, Mario Altieri, James Y. Findlay, Jae K. Oh, Kymberly D. Watt, Samuel S. Lee, on behalf of The Cirrhotic Cardiomyopathy Consortium – 25 July 2019 – Cirrhotic cardiomyopathy (CCM) is cardiac dysfunction in patients with end‐stage liver disease in the absence of prior heart disease. First defined in 2005 during the World Congress of Gastroenterology, CCM criteria consisted of echocardiographic parameters to identify subclinical cardiac dysfunction in the absence of overt structural abnormalities.